Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 May;118(1):1–19. doi: 10.1111/j.1476-5381.1996.tb15360.x

Fifteenth Gaddum Memorial Lecture December 1994. Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1.

J C Buckingham 1
PMCID: PMC1909484  PMID: 8733570

Full text

PDF
1

Images in this article

2Figure 1
on p.2
5Figure 5
on p.5
8Figure 8
on p.8
8Figure 9
on p.8

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angioni S., Petraglia F., Gallinelli A., Cossarizza A., Franceschi C., Muscettola M., Genazzani A. D., Surico N., Genazzani A. R. Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. Life Sci. 1993;53(23):1735–1742. doi: 10.1016/0024-3205(93)90160-5. [DOI] [PubMed] [Google Scholar]
  2. Arimura A., Bowers C. Y., Schally A. V., Saito M., Miller M. C., 3rd Effect of corticotropin-releasing factor, dexamethasone and actinomycin D on the release of ACTH from rat pituitaries in vivo and in vitro. Endocrinology. 1969 Aug;85(2):300–311. doi: 10.1210/endo-85-2-300. [DOI] [PubMed] [Google Scholar]
  3. Bartha L., Nagy G. M., Kiem D. T., Fekete M. I., Makara G. B. Inhibition of suckling-induced prolactin release by dexamethasone. Endocrinology. 1991 Aug;129(2):635–640. doi: 10.1210/endo-129-2-635. [DOI] [PubMed] [Google Scholar]
  4. Benker G., Raida M., Olbricht T., Wagner R., Reinhardt W., Reinwein D. TSH secretion in Cushing's syndrome: relation to glucocorticoid excess, diabetes, goitre, and the 'sick euthyroid syndrome'. Clin Endocrinol (Oxf) 1990 Dec;33(6):777–786. doi: 10.1111/j.1365-2265.1990.tb03915.x. [DOI] [PubMed] [Google Scholar]
  5. Besedovsky H. O., del Rey A. E., Sorkin E. Immune-neuroendocrine interactions. J Immunol. 1985 Aug;135(2 Suppl):750s–754s. [PubMed] [Google Scholar]
  6. Besedovsky H. O., del Rey A. Immune-neuroendocrine circuits: integrative role of cytokines. Front Neuroendocrinol. 1992 Jan;13(1):61–94. [PubMed] [Google Scholar]
  7. Besedovsky H. O., del Rey A., Schardt M., Sorkin E., Normann S., Baumann J., Girard J. Changes in plasma hormone profiles after tumor transplantation into syngeneic and allogeneic rats. Int J Cancer. 1985 Aug 15;36(2):209–216. doi: 10.1002/ijc.2910360213. [DOI] [PubMed] [Google Scholar]
  8. Besedovsky H., Sorkin E., Keller M., Müller J. Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med. 1975 Nov;150(2):466–470. doi: 10.3181/00379727-150-39057. [DOI] [PubMed] [Google Scholar]
  9. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Langham C. S., Parente L., Persico P., Russel-Smith N. C., Stone D. Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br J Pharmacol. 1982 May;76(1):185–194. doi: 10.1111/j.1476-5381.1982.tb09205.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980 Sep 11;287(5778):147–149. doi: 10.1038/287147a0. [DOI] [PubMed] [Google Scholar]
  11. Blalock J. E. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev. 1989 Jan;69(1):1–32. doi: 10.1152/physrev.1989.69.1.1. [DOI] [PubMed] [Google Scholar]
  12. Bolton C., Elderfield A. J., Flower R. J. The detection of lipocortins 1, 2 and 5 in central nervous system tissues from Lewis rats with acute experimental allergic encephalomyelitis. J Neuroimmunol. 1990 Sep-Oct;29(1-3):173–181. doi: 10.1016/0165-5728(90)90160-o. [DOI] [PubMed] [Google Scholar]
  13. Brabant G., Brabant A., Ranft U., Ocran K., Köhrle J., Hesch R. D., von zur Mühlen A. Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab. 1987 Jul;65(1):83–88. doi: 10.1210/jcem-65-1-83. [DOI] [PubMed] [Google Scholar]
  14. Briski K. P., Sylvester P. W. Inhibition of pituitary bioactive prolactin secretion in the male rat by the glucocorticoid agonist decadron phosphate. Biol Reprod. 1992 Sep;47(3):478–484. doi: 10.1095/biolreprod47.3.478. [DOI] [PubMed] [Google Scholar]
  15. Brown M. R., Hedge G. A. Effects of glucocorticoids on TRH and TSH secretion: dose and time considerations. Am J Physiol. 1974 Aug;227(2):289–294. doi: 10.1152/ajplegacy.1974.227.2.289. [DOI] [PubMed] [Google Scholar]
  16. Browning J. L., Ward M. P., Wallner B. P., Pepinsky R. B. Studies on the structural properties of lipocortin-1 and the regulation of its synthesis by steroids. Prog Clin Biol Res. 1990;349:27–45. [PubMed] [Google Scholar]
  17. Buckingham J. C. Effects of adrenocortical and gonadal steroids on the secretion in vitro of corticotrophin and its hypothalamic releasing factor. J Endocrinol. 1982 Apr;93(1):123–132. doi: 10.1677/joe.0.0930123. [DOI] [PubMed] [Google Scholar]
  18. Buckingham J. C., Hodges J. R. Functional activity of the hypothalamo-pituitary complex in the rat after betamethasone treatment. J Endocrinol. 1977 Aug;74(2):297–302. doi: 10.1677/joe.0.0740297. [DOI] [PubMed] [Google Scholar]
  19. Buckingham J. C., Hodges J. R. Production of corticotrophin releasing hormone by the isolated hypothalamus of the rat. J Physiol. 1977 Nov;272(2):469–479. doi: 10.1113/jphysiol.1977.sp012054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Buckingham J. C., Hodges J. R. The use of corticotrophin production by adenohypophysial tissue in vitro for the detection and estimation of potential corticotrophin releasing factors. J Endocrinol. 1977 Feb;72(2):187–193. doi: 10.1677/joe.0.0720187. [DOI] [PubMed] [Google Scholar]
  21. Buckingham J. C., Loxley H. D., Taylor A. D., Flower R. J. Cytokines, glucocorticoids and neuroendocrine function. Pharmacol Res. 1994 Jul;30(1):35–42. doi: 10.1016/1043-6618(94)80085-5. [DOI] [PubMed] [Google Scholar]
  22. Buckingham J. C. The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone. J Physiol. 1979 Jan;286:331–342. doi: 10.1113/jphysiol.1979.sp012622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Buckingham J. C. The influence of vasopressin on hypothalamic corticotrophin releasing activity in rats with inherited diabetes insipidus. J Physiol. 1981 Mar;312:9–16. doi: 10.1113/jphysiol.1981.sp013612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Buckingham J. C. Two distinct corticotrophin releasing activities of vasopressin. Br J Pharmacol. 1985 Jan;84(1):213–219. [PMC free article] [PubMed] [Google Scholar]
  25. Carey F., Forder R., Edge M. D., Greene A. R., Horan M. A., Strijbos P. J., Rothwell N. J. Lipocortin 1 fragment modifies pyrogenic actions of cytokines in rats. Am J Physiol. 1990 Aug;259(2 Pt 2):R266–R269. doi: 10.1152/ajpregu.1990.259.2.R266. [DOI] [PubMed] [Google Scholar]
  26. Carón R. W., Salicioni A. M., Deis R. P. Mifepristone treatment demonstrates the participation of adrenal glucocorticoids in the regulation of oestrogen-induced prolactin secretion in ovariectomized rats. J Steroid Biochem Mol Biol. 1994 Mar;48(4):385–389. doi: 10.1016/0960-0760(94)90079-5. [DOI] [PubMed] [Google Scholar]
  27. Chen C. Y., Shyu A. B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci. 1995 Nov;20(11):465–470. doi: 10.1016/s0968-0004(00)89102-1. [DOI] [PubMed] [Google Scholar]
  28. Cirino G., Peers S. H., Flower R. J., Browning J. L., Pepinsky R. B. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc Natl Acad Sci U S A. 1989 May;86(9):3428–3432. doi: 10.1073/pnas.86.9.3428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Coméra C., Russo-Marie F. Glucocorticoid-induced annexin 1 secretion by monocytes and peritoneal leukocytes. Br J Pharmacol. 1995 Jul;115(6):1043–1047. doi: 10.1111/j.1476-5381.1995.tb15916.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Copinschi G., L'Hermite M., Leclercq R., Golstein J., Vanhaelst L., Virasoro E., Robyn C. Effects of glucocorticoids on pituitary hormonal responses to hypoglycemia. Inhibition of prolactin release. J Clin Endocrinol Metab. 1975 Mar;40(3):442–449. doi: 10.1210/jcem-40-3-442. [DOI] [PubMed] [Google Scholar]
  31. Cowell A. M., Buckingham J. C. Eicosanoids and the hypothalamo-pituitary axis. Prostaglandins Leukot Essent Fatty Acids. 1989 Jun;36(4):235–250. doi: 10.1016/0952-3278(89)90136-1. [DOI] [PubMed] [Google Scholar]
  32. Cowell A. M., Flower R. J., Buckingham J. C. Studies on the roles of phospholipase A2 and eicosanoids in the regulation of corticotrophin secretion by rat pituitary cells in vitro. J Endocrinol. 1991 Jul;130(1):21–32. doi: 10.1677/joe.0.1300021. [DOI] [PubMed] [Google Scholar]
  33. Crompton M. R., Moss S. E., Crumpton M. J. Diversity in the lipocortin/calpactin family. Cell. 1988 Oct 7;55(1):1–3. doi: 10.1016/0092-8674(88)90002-5. [DOI] [PubMed] [Google Scholar]
  34. Croxtall J. D., Flower R. J. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3571–3575. doi: 10.1073/pnas.89.8.3571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Dayanithi G., Antoni F. A. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein. Endocrinology. 1989 Jul;125(1):308–313. doi: 10.1210/endo-125-1-308. [DOI] [PubMed] [Google Scholar]
  36. De Simoni M. G., Del Bo R., De Luigi A., Simard S., Forloni G. Central endotoxin induces different patterns of interleukin (IL)-1 beta and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery. Endocrinology. 1995 Mar;136(3):897–902. doi: 10.1210/endo.136.3.7867598. [DOI] [PubMed] [Google Scholar]
  37. Derijk R., Sternberg E. M. Corticosteroid action and neuroendocrine-immune interactions. Ann N Y Acad Sci. 1994 Nov 30;746:33–67. doi: 10.1111/j.1749-6632.1994.tb39208.x. [DOI] [PubMed] [Google Scholar]
  38. Dunn A. J. Nervous system-immune system interactions: an overview. J Recept Res. 1988;8(1-4):589–607. doi: 10.3109/10799898809049013. [DOI] [PubMed] [Google Scholar]
  39. Elderfield A. J., Newcombe J., Bolton C., Flower R. J. Lipocortins (annexins) 1, 2, 4 and 5 are increased in the central nervous system in multiple sclerosis. J Neuroimmunol. 1992 Jul;39(1-2):91–100. doi: 10.1016/0165-5728(92)90178-n. [DOI] [PubMed] [Google Scholar]
  40. Francis J. W., Balazovich K. J., Smolen J. E., Margolis D. I., Boxer L. A. Human neutrophil annexin I promotes granule aggregation and modulates Ca(2+)-dependent membrane fusion. J Clin Invest. 1992 Aug;90(2):537–544. doi: 10.1172/JCI115892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Frohman L. A., Downs T. R., Chomczynski P. Regulation of growth hormone secretion. Front Neuroendocrinol. 1992 Oct;13(4):344–405. [PubMed] [Google Scholar]
  42. Gebicke-Haerter P. J., Schobert A., Dieter P., Honegger P., Hertting G. Regulation and glucocorticoid-independent induction of lipocortin I in cultured astrocytes. J Neurochem. 1991 Jul;57(1):175–183. doi: 10.1111/j.1471-4159.1991.tb02113.x. [DOI] [PubMed] [Google Scholar]
  43. Geisow M. J., Fritsche U., Hexham J. M., Dash B., Johnson T. A consensus amino-acid sequence repeat in Torpedo and mammalian Ca2+-dependent membrane-binding proteins. Nature. 1986 Apr 17;320(6063):636–638. doi: 10.1038/320636a0. [DOI] [PubMed] [Google Scholar]
  44. Gillies G. E., Buckingham J. C. The application of in vitro models of anterior pituitary function in toxicity testing. Methods Mol Biol. 1995;43:81–93. doi: 10.1385/0-89603-282-5:81. [DOI] [PubMed] [Google Scholar]
  45. Gillies G. E., Buckingham J. C. The application of in vitro models of hypothalamic function in toxicity testing. Methods Mol Biol. 1995;43:95–107. doi: 10.1385/0-89603-282-5:95. [DOI] [PubMed] [Google Scholar]
  46. Gillies G. E., Linton E. A., Lowry P. J. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature. 1982 Sep 23;299(5881):355–357. doi: 10.1038/299355a0. [DOI] [PubMed] [Google Scholar]
  47. Glaser K. B., Mobilio D., Chang J. Y., Senko N. Phospholipase A2 enzymes: regulation and inhibition. Trends Pharmacol Sci. 1993 Mar;14(3):92–98. doi: 10.1016/0165-6147(93)90071-q. [DOI] [PubMed] [Google Scholar]
  48. Goulding N. J., Guyre P. M. Lipocortin 1 binding to human leukocytes correlates with its ability to inhibit IgG interactions with Fc gamma receptors. Biochem Biophys Res Commun. 1993 Apr 30;192(2):351–358. doi: 10.1006/bbrc.1993.1422. [DOI] [PubMed] [Google Scholar]
  49. Goulding N. J., Jefferiss C. M., Pan L., Rigby W. F., Guyre P. M. Specific binding of lipocortin-1 (annexin I) to monocytes and neutrophils is decreased in rheumatoid arthritis. Arthritis Rheum. 1992 Nov;35(11):1395–1397. doi: 10.1002/art.1780351126. [DOI] [PubMed] [Google Scholar]
  50. Hagan P., Poole S., Bristow A. F. Endotoxin-stimulated production of rat hypothalamic interleukin-1 beta in vivo and in vitro, measured by specific immunoradiometric assay. J Mol Endocrinol. 1993 Aug;11(1):31–36. doi: 10.1677/jme.0.0110031. [DOI] [PubMed] [Google Scholar]
  51. Heyward P. M., Clarke I. J. A transient effect of estrogen on calcium currents and electrophysiological responses to gonadotropin-releasing hormone in ovine gonadotropes. Neuroendocrinology. 1995 Dec;62(6):543–552. doi: 10.1159/000127050. [DOI] [PubMed] [Google Scholar]
  52. Horlick K. R., Cheng I. C., Wong W. T., Wakeland E. K., Nick H. S. Mouse lipocortin I gene structure and chromosomal assignment: gene duplication and the origins of a gene family. Genomics. 1991 Jun;10(2):365–374. doi: 10.1016/0888-7543(91)90321-5. [DOI] [PubMed] [Google Scholar]
  53. Houben H., Denef C. Negative regulation by dexamethasone of the potentiation of neuromedin C-induced growth hormone and prolactin release by estradiol in anterior pituitary cell aggregates. Life Sci. 1992;50(11):775–780. doi: 10.1016/0024-3205(92)90182-o. [DOI] [PubMed] [Google Scholar]
  54. Imura H., Fukata J., Mori T. Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Clin Endocrinol (Oxf) 1991 Aug;35(2):107–115. doi: 10.1111/j.1365-2265.1991.tb03506.x. [DOI] [PubMed] [Google Scholar]
  55. Iovino M., Steardo L., Monteleone P. Impaired sensitivity of the hypothalamo-pituitary-thyroid axis to the suppressant effect of dexamethasone in elderly subjects. Psychopharmacology (Berl) 1991;105(4):481–484. doi: 10.1007/BF02244367. [DOI] [PubMed] [Google Scholar]
  56. Ismail A. A., Burr W. A., Walker P. L. Acute changes in serum thyrotrophin in treated Addison's disease. Clin Endocrinol (Oxf) 1989 Mar;30(3):225–230. doi: 10.1111/j.1365-2265.1989.tb02230.x. [DOI] [PubMed] [Google Scholar]
  57. Israel J. M., Jaquet P., Vincent J. D. The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine. Endocrinology. 1985 Oct;117(4):1448–1455. doi: 10.1210/endo-117-4-1448. [DOI] [PubMed] [Google Scholar]
  58. Jingami H., Matsukura S., Numa S., Imura H. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. Endocrinology. 1985 Oct;117(4):1314–1320. doi: 10.1210/endo-117-4-1314. [DOI] [PubMed] [Google Scholar]
  59. Johnson M. D., Kamso-Pratt J., Pepinsky R. B., Whetsell W. O., Jr Lipocortin-1 immunoreactivity in central and peripheral nervous system glial tumors. Hum Pathol. 1989 Aug;20(8):772–776. doi: 10.1016/0046-8177(89)90071-3. [DOI] [PubMed] [Google Scholar]
  60. Jones M. T., Gillham B. Factors involved in the regulation of adrenocorticotropic hormone/beta-lipotropic hormone. Physiol Rev. 1988 Jul;68(3):743–818. doi: 10.1152/physrev.1988.68.3.743. [DOI] [PubMed] [Google Scholar]
  61. Keller-Wood M. E., Dallman M. F. Corticosteroid inhibition of ACTH secretion. Endocr Rev. 1984 Winter;5(1):1–24. doi: 10.1210/edrv-5-1-1. [DOI] [PubMed] [Google Scholar]
  62. Kim K. M., Kim D. K., Park Y. M., Kim C. K., Na D. S. Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett. 1994 May 2;343(3):251–255. doi: 10.1016/0014-5793(94)80566-0. [DOI] [PubMed] [Google Scholar]
  63. Kovacic R. T., Tizard R., Cate R. L., Frey A. Z., Wallner B. P. Correlation of gene and protein structure of rat and human lipocortin I. Biochemistry. 1991 Sep 17;30(37):9015–9021. doi: 10.1021/bi00101a015. [DOI] [PubMed] [Google Scholar]
  64. Lamberts S. W., Macleod R. M. Regulation of prolactin secretion at the level of the lactotroph. Physiol Rev. 1990 Apr;70(2):279–318. doi: 10.1152/physrev.1990.70.2.279. [DOI] [PubMed] [Google Scholar]
  65. Layé S., Bluthé R. M., Kent S., Combe C., Médina C., Parnet P., Kelley K., Dantzer R. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am J Physiol. 1995 May;268(5 Pt 2):R1327–R1331. doi: 10.1152/ajpregu.1995.268.5.R1327. [DOI] [PubMed] [Google Scholar]
  66. Levitan E. S., Hemmick L. M., Birnberg N. C., Kaczmarek L. K. Dexamethasone increases potassium channel messenger RNA and activity in clonal pituitary cells. Mol Endocrinol. 1991 Dec;5(12):1903–1908. doi: 10.1210/mend-5-12-1903. [DOI] [PubMed] [Google Scholar]
  67. Long J. B., Holaday J. W. Blood-brain barrier: endogenous modulation by adrenal-cortical function. Science. 1985 Mar 29;227(4694):1580–1583. doi: 10.1126/science.3975627. [DOI] [PubMed] [Google Scholar]
  68. Lowry P. J. The corticotrophin-releasing factor-binding protein: from artefact to new ligand(s) and axis. J Endocrinol. 1995 Jan;144(1):1–4. doi: 10.1677/joe.0.1440001. [DOI] [PubMed] [Google Scholar]
  69. Loxley H. D., Cowell A. M., Flower R. J., Buckingham J. C. Effects of lipocortin 1 and dexamethasone on the secretion of corticotrophin-releasing factors in the rat: in vitro and in vivo studies. J Neuroendocrinol. 1993 Feb;5(1):51–61. doi: 10.1111/j.1365-2826.1993.tb00363.x. [DOI] [PubMed] [Google Scholar]
  70. Loxley H. D., Cowell A. M., Flower R. J., Buckingham J. C. Modulation of the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat by lipocortin 1 and glucocorticoids: a role for lipocortin 1 in the feedback inhibition of CRF-41 release? Neuroendocrinology. 1993 May;57(5):801–814. doi: 10.1159/000126439. [DOI] [PubMed] [Google Scholar]
  71. López-Calderón A., Ariznavarreta C., Calderón M. D., Tresguerres J. A., Gonzalez-Quijano M. I. Role of the adrenal cortex in chronic stress-induced inhibition of prolactin secretion in male rats. J Endocrinol. 1989 Feb;120(2):269–273. doi: 10.1677/joe.0.1200269. [DOI] [PubMed] [Google Scholar]
  72. Maes M., D'Hondt P., Blockx P., Cosyns P. A further investigation of basal HPT axis function in unipolar depression: effects of diagnosis, hospitalization, and dexamethasone administration. Psychiatry Res. 1994 Feb;51(2):185–201. doi: 10.1016/0165-1781(94)90038-8. [DOI] [PubMed] [Google Scholar]
  73. McKanna J. A. Lipocortin 1 immunoreactivity identifies microglia in adult rat brain. J Neurosci Res. 1993 Nov 1;36(4):491–500. doi: 10.1002/jnr.490360415. [DOI] [PubMed] [Google Scholar]
  74. McKanna J. A. Primitive glial compartments in the floor plate of mammalian embryos: distinct progenitors of adult astrocytes and microglia support the notoplate hypothesis. Perspect Dev Neurobiol. 1993;1(4):245–255. [PubMed] [Google Scholar]
  75. McLeod J. D., Bolton C. Dexamethasone induces an increase in intracellular and membrane-associated lipocortin-1 (annexin-1) in rat astrocyte primary cultures. Cell Mol Neurobiol. 1995 Apr;15(2):193–205. doi: 10.1007/BF02073328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. McLeod J. D., Goodall A., Jelic P., Bolton C. Changes in the cellular distribution of lipocortin-1 (Annexin-1) in C6 glioma cells after exposure to dexamethasone. Biochem Pharmacol. 1995 Sep 28;50(7):1103–1107. doi: 10.1016/0006-2952(95)00234-q. [DOI] [PubMed] [Google Scholar]
  77. Mitsuma T., Nogimori T. Effects of adrenalectomy on the hypothalamic-pituitary-thyroid axis in rats. Horm Metab Res. 1982 Jun;14(6):317–319. doi: 10.1055/s-2007-1019004. [DOI] [PubMed] [Google Scholar]
  78. Mullens L., Marriott D. R., Young K. A., Tannahill L., Lightman S. L., Wilkin G. P. Up-regulation of lipocortin-1 and its mRNA in reactive astrocytes in kainate-lesioned rat cerebellum. J Neuroimmunol. 1994 Feb;50(1):25–33. doi: 10.1016/0165-5728(94)90211-9. [DOI] [PubMed] [Google Scholar]
  79. Munck A., Guyre P. M., Holbrook N. J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984 Winter;5(1):25–44. doi: 10.1210/edrv-5-1-25. [DOI] [PubMed] [Google Scholar]
  80. Muramami N., Fukata J., Tsukada T., Kobayashi H., Ebisui O., Segawa H., Muro S., Imura H., Nakao K. Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland, and spleen. Endocrinology. 1993 Dec;133(6):2574–2578. doi: 10.1210/endo.133.6.8243280. [DOI] [PubMed] [Google Scholar]
  81. Nicoloff J. T., Spencer C. A. Integration of thyroid hormones with hypothalamic factors on pituitary TSH secretion. Acta Med Austriaca. 1992;19 (Suppl 1):68–71. [PubMed] [Google Scholar]
  82. Nishino Y., Michna H., Hasan S. H., Schneider M. R. Involvement of the adrenal glands in the prolactin rise induced in the female rat by an antiprogestin, onapristone. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):841–845. doi: 10.1016/0960-0760(92)90435-l. [DOI] [PubMed] [Google Scholar]
  83. Pamenter R. W., Hedge G. A. Inhibition of thyrotropin secretion by physiological levels of corticosterone. Endocrinology. 1980 Jan;106(1):162–166. doi: 10.1210/endo-106-1-162. [DOI] [PubMed] [Google Scholar]
  84. Perretti M., Ahluwalia A., Harris J. G., Goulding N. J., Flower R. J. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody. J Immunol. 1993 Oct 15;151(8):4306–4314. [PubMed] [Google Scholar]
  85. Perretti M., Flower R. J. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol. 1993 Feb 1;150(3):992–999. [PubMed] [Google Scholar]
  86. Piroli G., Grillo C., Ferrini M., Diaz-Torga G., Libertun C., De Nicola A. F. Restoration by bromocriptine of glucocorticoid receptors and glucocorticoid negative feedback on prolactin secretion in estrogen-induced pituitary tumors. Neuroendocrinology. 1993 Sep;58(3):273–279. doi: 10.1159/000126550. [DOI] [PubMed] [Google Scholar]
  87. Re R. N., Kourides I. A., Ridgway E. C., Weintraub B. D., Maloof F. The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab. 1976 Aug;43(2):338–346. doi: 10.1210/jcem-43-2-338. [DOI] [PubMed] [Google Scholar]
  88. Regnouf F., Rendon A., Pradel L. A. Biochemical characterization of annexins I and II isolated from pig nervous tissue. J Neurochem. 1991 Jun;56(6):1985–1996. doi: 10.1111/j.1471-4159.1991.tb03457.x. [DOI] [PubMed] [Google Scholar]
  89. Relton J. K., Strijbos P. J., O'Shaughnessy C. T., Carey F., Forder R. A., Tilders F. J., Rothwell N. J. Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J Exp Med. 1991 Aug 1;174(2):305–310. doi: 10.1084/jem.174.2.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Reul J. M., van den Bosch F. R., de Kloet E. R. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J Endocrinol. 1987 Dec;115(3):459–467. doi: 10.1677/joe.0.1150459. [DOI] [PubMed] [Google Scholar]
  91. Robberecht W., Andries M., Denef C. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor. Neuroendocrinology. 1992 Aug;56(2):185–194. doi: 10.1159/000126227. [DOI] [PubMed] [Google Scholar]
  92. Roche P. J., Crawford R. J., Fernley R. T., Tregear G. W., Coghlan J. P. Nucleotide sequence of the gene coding for ovine corticotropin-releasing factor and regulation of its mRNA levels by glucocorticoids. Gene. 1988 Nov 30;71(2):421–431. doi: 10.1016/0378-1119(88)90059-5. [DOI] [PubMed] [Google Scholar]
  93. Rossi F., Forgione A. Pharmacotoxicological aspects of levosulpiride. Pharmacol Res. 1995 Feb;31(2):81–94. doi: 10.1016/1043-6618(95)80052-2. [DOI] [PubMed] [Google Scholar]
  94. Rossier J., French E., Rivier C., Shibasaki T., Guillemin R., Bloom F. E. Stress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation. Proc Natl Acad Sci U S A. 1980 Jan;77(1):666–669. doi: 10.1073/pnas.77.1.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Rubello D., Sonino N., Casara D., Girelli M. E., Busnardo B., Boscaro M. Acute and chronic effects of high glucocorticoid levels on hypothalamic-pituitary-thyroid axis in man. J Endocrinol Invest. 1992 Jun;15(6):437–441. doi: 10.1007/BF03348767. [DOI] [PubMed] [Google Scholar]
  96. Samuels M. H., Luther M., Henry P., Ridgway E. C. Effects of hydrocortisone on pulsatile pituitary glycoprotein secretion. J Clin Endocrinol Metab. 1994 Jan;78(1):211–215. doi: 10.1210/jcem.78.1.8288706. [DOI] [PubMed] [Google Scholar]
  97. Sawchenko P. E. Adrenalectomy-induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: anatomic, peptide, and steroid specificity. J Neurosci. 1987 Apr;7(4):1093–1106. doi: 10.1523/JNEUROSCI.07-04-01093.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Sawchenko P. E., Swanson L. W., Vale W. W. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1883–1887. doi: 10.1073/pnas.81.6.1883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Schofield J. G. Use of a trapped fluorescent indicator to demonstrate effects of thyroliberin and dopamine on cytoplasmic calcium concentrations in bovine anterior pituitary cells. FEBS Lett. 1983 Aug 8;159(1-2):79–82. doi: 10.1016/0014-5793(83)80420-7. [DOI] [PubMed] [Google Scholar]
  100. Shek P. N., Sabiston B. H. Neuroendocrine regulation of immune processes: change in circulating corticosterone levels induced by the primary antibody response in mice. Int J Immunopharmacol. 1983;5(1):23–33. doi: 10.1016/0192-0561(83)90068-1. [DOI] [PubMed] [Google Scholar]
  101. Smith T., Smith S. F., Buckingham J. C. A competitive enzyme-linked immunosorbent assay for the estimation of rat lipocortin 1. Biochem Soc Trans. 1990 Dec;18(6):1230–1231. doi: 10.1042/bst0181230. [DOI] [PubMed] [Google Scholar]
  102. Stenzel-Poore M., Vale W. W., Rivier C. Relationship between antigen-induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology. 1993 Mar;132(3):1313–1318. doi: 10.1210/endo.132.3.8382598. [DOI] [PubMed] [Google Scholar]
  103. Strijbos P. J., Tilders F. J., Carey F., Forder R., Rothwell N. J. Localization of immunoreactive lipocortin-1 in the brain and pituitary gland of the rat. Effects of adrenalectomy, dexamethasone and colchicine treatment. Brain Res. 1991 Jul 12;553(2):249–260. doi: 10.1016/0006-8993(91)90833-h. [DOI] [PubMed] [Google Scholar]
  104. Taraskevich P. S., Douglas W. W. Catecholamines of supposed inhibitory hypophysiotrophic function suppress action potentials in prolactin cells. Nature. 1978 Dec 21;276(5690):832–834. doi: 10.1038/276832a0. [DOI] [PubMed] [Google Scholar]
  105. Taylor A. D., Cowell A. M., Flower J., Buckingham J. C. Lipocortin 1 mediates an early inhibitory action of glucocorticoids on the secretion of ACTH by the rat anterior pituitary gland in vitro. Neuroendocrinology. 1993 Oct;58(4):430–439. doi: 10.1159/000126572. [DOI] [PubMed] [Google Scholar]
  106. Taylor A. D., Cowell A. M., Flower R. J., Buckingham J. C. Dexamethasone suppresses the release of prolactin from the rat anterior pituitary gland by lipocortin 1 dependent and independent mechanisms. Neuroendocrinology. 1995 Nov;62(5):530–542. doi: 10.1159/000127044. [DOI] [PubMed] [Google Scholar]
  107. Taylor A. D., Flower R. J., Buckingham J. C. Dexamethasone inhibits the release of TSH from the rat anterior pituitary gland in vitro by mechanisms dependent on de novo protein synthesis and lipocortin 1. J Endocrinol. 1995 Dec;147(3):533–544. doi: 10.1677/joe.0.1470533. [DOI] [PubMed] [Google Scholar]
  108. Taylor A. D., Loxley H. D., Flower R. J., Buckingham J. C. Immunoneutralization of lipocortin 1 reverses the acute inhibitory effects of dexamethasone on the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat in vitro and in vivo. Neuroendocrinology. 1995 Jul;62(1):19–31. doi: 10.1159/000126984. [DOI] [PubMed] [Google Scholar]
  109. Tsagarakis S., Gillies G., Rees L. H., Besser M., Grossman A. Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus. Neuroendocrinology. 1989 Jan;49(1):98–101. doi: 10.1159/000125096. [DOI] [PubMed] [Google Scholar]
  110. Vadas P., Hay J. B. Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock. Can J Physiol Pharmacol. 1983 Jun;61(6):561–566. doi: 10.1139/y83-086. [DOI] [PubMed] [Google Scholar]
  111. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981 Sep 18;213(4514):1394–1397. doi: 10.1126/science.6267699. [DOI] [PubMed] [Google Scholar]
  112. Vinge E., Erfurth E. M., Lundin S. Effects of adrenal function tests on the levels of endogenous digitalis-like substances and some pituitary hormones. Acta Endocrinol (Copenh) 1993 Jan;128(1):29–34. doi: 10.1530/acta.0.1280029. [DOI] [PubMed] [Google Scholar]
  113. Violette S. M., King I., Browning J. L., Pepinsky R. B., Wallner B. P., Sartorelli A. C. Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. J Cell Physiol. 1990 Jan;142(1):70–77. doi: 10.1002/jcp.1041420110. [DOI] [PubMed] [Google Scholar]
  114. Wallner B. P., Mattaliano R. J., Hession C., Cate R. L., Tizard R., Sinclair L. K., Foeller C., Chow E. P., Browing J. L., Ramachandran K. L. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature. 1986 Mar 6;320(6057):77–81. doi: 10.1038/320077a0. [DOI] [PubMed] [Google Scholar]
  115. Watanobe H. The immunostaining for the hypothalamic vasoactive intestinal peptide, but not for beta-endorphin, dynorphin-A or methionine-enkephalin, is affected by the glucocorticoid milieu in the rat: correlation with the prolactin secretion. Regul Pept. 1990 May 21;28(3):301–311. doi: 10.1016/0167-0115(90)90028-u. [DOI] [PubMed] [Google Scholar]
  116. Yasin S. A., Costa A., Forsling M. L., Grossman A. Interleukin-1 beta and interleukin-6 stimulate neurohypophysial hormone release in vitro. J Neuroendocrinol. 1994 Apr;6(2):179–184. doi: 10.1111/j.1365-2826.1994.tb00570.x. [DOI] [PubMed] [Google Scholar]
  117. Yelvington D. B., Weiss G. K., Ratner A. Effect of corticosterone on the prolactin response to psychological and physical stress in rats. Life Sci. 1984 Oct 15;35(16):1705–1711. doi: 10.1016/0024-3205(84)90183-8. [DOI] [PubMed] [Google Scholar]
  118. Zaloga G. P., Chernow B., Smallridge R. C., Zajtchuk R., Hall-Boyer K., Hargraves R., Lake C. R., Burman K. D. A longitudinal evaluation of thyroid function in critically ill surgical patients. Ann Surg. 1985 Apr;201(4):456–464. doi: 10.1097/00000658-198504000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES